Director sold ~$6.4M of CVS shares in the open market

Past results only. Not a forecast.

Record ID

0000905148-26-002617

Filed / recorded

May 21, 2026, 9:43 PM UTC

Added to OQRO

Oct 2, 2026, 3:52 AM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

CVS HEALTH Corp

Issuer CIK

64803

Ticker

CVS

Reporting person

Larry Robbins

Relationship

Director

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

May 20, 2026

Transaction code

S

Shares / units

66,881

Price per share

$95.6655

Acquired / disposed

Disposed (D)

Shares owned after

5,196,061

Ownership form

Indirect — Held by Glenview Investment Funds

Amendment

No

1. These shares of the Issuer's common stock (the "Shares") are held for the accounts of Glenview Capital Master Fund, Ltd., Glenview Offshore Opportunity Master Fund, Ltd. (the "GO Fund"), Glenview Healthcare Master Fund, L.P., and GCM Suggestivist I Master Fund, L.P. (collectively, the "Glenview Investment Funds").
2. This price reflects the weighted average price for open-market sales of Shares on May 20, 2026 within a $1.00 range. The actual prices for these transactions range from $95.25 to $96.21, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.
3. The Reporting Person disclaims beneficial ownership over any securities owned by the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein.
4. The Glenview Investment Funds are the record holders of the Shares. The Reporting Person is the Founder, Portfolio Manager and CIO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. The Reporting Person shares voting and dispositive power over the Shares held by the Glenview Investment Funds and may be deemed to beneficially own such Shares.